Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The company (under the former name Shinkowa Pharmaceutical) conducted and sponsored early human clinical and academic studies on long‑term oral intake of β‑nicotinamide mononucleotide (NMN), reporting biomarker changes such as Sirtuin 1 expression and hormone alterations, and has since commercialized multiple NMN-based supplements and cosmetics, but does not operate prescription drug clinical trials.[1][3]
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Mirailab Bioscience.